Although the
complement system has been implicated in
atherosclerosis, the influence of membrane-bound
complement regulators in this process has not been well understood. We studied the role of two membrane
complement regulators,
decay-accelerating factor (DAF) and CD59, in a murine model of
atherosclerosis. DAF(-/-) and CD59(-/-) mice were crossed with
apolipoprotein E (
ApoE)-deficient mice to generate DAF(-/-)
ApoE(-/-) and CD59(-/-)
ApoE(-/-) mice. Mice were fed a high fat diet (HFD) for 8 or 16 weeks. En face analysis showed that
CD59 deficiency led to more extensive lesions in female
ApoE(-/-) mice both at 8 weeks (2.07+/-0.27% vs.1.34+/-0.21%, P=0.06) and 16 weeks (17.13+/-1.14% vs. 9.72+/-1.14%, P<0.001). Similarly, lesions measured by aortic root sectioning were larger in female CD59(-/-)
ApoE(-/-) mice than in controls at 8 weeks of HFD feeding (20.74+/-1.33% vs. 13.12+/-1.46%, P<0.005). On the other hand, DAF deficiency did not significantly influence
atherosclerosis in
ApoE(-/-) mice. Immunohistochemistry revealed more abundant
membrane attack complex (MAC) deposition and more
collagen staining in the aortic roots of CD59(-/-)
ApoE(-/-) mice. Unexpectedly, total plasma
cholesterol levels in female CD59(-/-)
ApoE(-/-) mice were found to be elevated compared with CD59(+/+)
ApoE(-/-) mice. We conclude that CD59 but not DAF offered protection in
atherosclerosis in the context of
ApoE deficiency. The protective role of CD59 was gender-biased and most likely involved prevention of MAC-mediated
vascular injury, with possible contribution from an undefined effect on plasma
cholesterol homeostasis.